Suchen
CorMedix Inc
CRMDZur Watchlist hinzufügen
7.770USD
+0.080+1.04%
Handelsschluss 09-24 16:00（ET）
609.56MMarktkapitalisierung
3.19KGV TTM
Über CorMedix Inc Unternehmen
CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product, DefenCath, which is an antimicrobial catheter lock solution approved to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter. DefenCath is a formulation of taurolidine 13.5 milligrams per milliliter (mg/mL), and heparin 1000 USP Units/mL indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter (CVC). The Company is also commercializing a portfolio of anti-infective products including MINOCIN, REZZAYO, VABOMERE, ORBACTIV, BAXDELA, and KIMYRSA, as well as TOPROL-XL.
CorMedix Inc Profil
BörsenkürzelCRMD
Name des UnternehmensCorMedix Inc
IPO-datumMar 25, 2010
CEOTodisco (Joseph)
Anzahl der mitarbeiter64
WertpapierartOrdinary Share
GeschäftsjahresendeMar 25
Addresse300 Connell Drive
StadtBERKELEY HEIGHTS
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl07922
Telefon19085179500
Websitehttps://cormedix.com/
BörsenkürzelCRMD
IPO-datumMar 25, 2010
CEOTodisco (Joseph)
Führungskräfte von CorMedix Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Joseph (Joe) Todisco
Mr. Joseph (Joe) Todisco
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
401.08K
-41.48%
Mr. Joseph (Joe) Todisco
Mr. Joseph (Joe) Todisco
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
401.08K
-41.48%
Mr. Joseph (Joe) Todisco
Mr. Joseph (Joe) Todisco
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
401.08K
-41.48%
Mr. Steven W. Lefkowitz
Mr. Steven W. Lefkowitz
Independent Director
Independent Director
127.65K
-4.27%
Mr. Steven W. Lefkowitz
Mr. Steven W. Lefkowitz
Independent Director
Independent Director
127.65K
-4.27%
Mr. Steven W. Lefkowitz
Mr. Steven W. Lefkowitz
Independent Director
Independent Director
127.65K
-4.27%
Ms. Susan Blum
Ms. Susan Blum
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
124.31K
-6.78%
Ms. Susan Blum
Ms. Susan Blum
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
124.31K
-6.78%
Ms. Susan Blum
Ms. Susan Blum
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
124.31K
-6.78%
Ms. Janet M. Dillione
Ms. Janet M. Dillione
Independent Director
Independent Director
87.38K
+55.97%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Joseph (Joe) Todisco
Mr. Joseph (Joe) Todisco
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
401.08K
-41.48%
Mr. Joseph (Joe) Todisco
Mr. Joseph (Joe) Todisco
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
401.08K
-41.48%
Mr. Joseph (Joe) Todisco
Mr. Joseph (Joe) Todisco
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
401.08K
-41.48%
Mr. Steven W. Lefkowitz
Mr. Steven W. Lefkowitz
Independent Director
Independent Director
127.65K
-4.27%
Mr. Steven W. Lefkowitz
Mr. Steven W. Lefkowitz
Independent Director
Independent Director
127.65K
-4.27%
Mr. Steven W. Lefkowitz
Mr. Steven W. Lefkowitz
Independent Director
Independent Director
127.65K
-4.27%
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von CorMedix Inc?
Die fünf größten Anteilseigner von CorMedix Inc sind: Mr. Joseph (Joe) Todisco
Wie viele Institutionen halten Anteile an CorMedix Inc (CRMD)?
Mit Stand vom 2026Q1 halten 390 Institutionen Anteile an CorMedix Inc, mit einem Gesamtmarktwert von etwa 43.28M, was 55.17% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -18630389.00 gestiegen.